Pelacarsen is an antisense therapy that is designed to reduce Lipoprotein(a) concentrations in people with high levels of the lipoprotein and who are at risk of cardiovascular disease.
[1][2][3] It was developed by Ionis Pharmaceuticals and Novartis.
[4]
This pharmacology-related article is a stub.
You can help Wikipedia by expanding it.